Sickle Cell Anemia Testing and Screening Market - Databook 2025 to 2034

The global sickle cell anemia testing and screening market size was evaluated at USD 479.09 million in 2024 and is expected to grow around USD 13,50.07 million by 2034, registering a CAGR of 12.2% from 2025 to 2034.

Highlights of the Sickle Cell Anemia Testing and Screening Market

• North America dominated the sickle cell anemia testing and screening market in 2024.
• Europe is expected to show the fastest growth in the forecasted period of 2025-2034.
• By technology, the hemoglobin electrophoresis segment accounted for a considerable share of the market in 2024.
• By technology, the High-Performance Liquid Chromatography (HPLC) segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By age group, the newborn screening (12 months and below) segment registered its dominance over the market in 2024.
• By age group, the Adult Screening (25 to 60 years) segment is projected to experience the highest growth rate in the market between 2025 and 2034
• By sector, the government labs segment maintained a leading position in the market in 2024
• By sector, the private labs segment is set to experience the fastest rate of market growth from 2025 to 2034.

Industry Valuation and Growth Rate Projection

Sickle cell anemia testing is the process of identifying the presence of abnormal hemoglobin (HbS) through blood tests and genetic tests on individuals. This test can confirm whether the individual has sickle cell disease or other traits. Screening for sickle cell anemia involves testing the blood of an individual with a complete blood count to detect abnormal hemoglobin.

The sickle cell anemia testing and screening market is rapidly growing due to the rise in the number of patients with sickle cell disease. An increase in the awareness for such testing & screening with investment by the government in the healthcare sector and biotech boosts market growth.

Sickle Cell Anemia Testing and Screening Market: Stats and Figures

• The UN estimates that around 385,000 babies are born each day around the world (140 million a year).
• Globally, more than 8 million people are affected with the sickle cell disease, of which more than 100,00 affected people come from the United States.

Industry Leader Announcements

• Matthew Kreifels, Vice President of Sales, MarCom and Business Development:

“Protein Plus BCT is an excellent addition to the Streck stabilization line. We are excited to enter the rapidly growing field of proteomics and are enthusiastic to provide a tool that not only improves laboratory efficiency but also gives customers confidence in the accuracy of their results.”

• Carolyn Reifsnyder, Senior Director of Marketing at Bio-Rad:

"As the number of cell and gene therapies entering the market increases, we see a growing emphasis on the need for products to ensure safety and efficacy across production processes. We believe that Droplet Digital PCR solutions can help address this unmet need. The introduction of Bio-Rad’s newest Vericheck ddPCR kits for RCL and RCAAV to our growing portfolio reflects our ongoing commitment to providing innovative QC tools to support advances in the cell and gene therapy space."

How AI has Benefitted the Sickle Cell Anemia Testing and Screening Market

• Artificial Intelligence (AI) is being increasingly used in the healthcare sector and helps in improving accuracy for the detection of sickle cell disease.
• AI also helps in the early detection of chronic diseases in patients with high risk, which allows quicker treatment and efficient resource allocation.
• AI helps reduce manual labor costs by automating processes with much more efficiency and accuracy, eliminating any human error.
• AI also helps patients receive personalized medicine through data-driven insights and can predict which patients are at a higher risk.

Recent Developments

• In June 2024, Streck announced its partnership with Longhorn Vaccines and Diagnostics for the distribution of its flagship product. PrimeStore Molecular Transport Media (MTM), worldwide.
• In April 2024, Streck announced the launch of its new blood collection tube, Protein Plus BCT, for use only for research purposes. It is a direct draw whole blood collection tube intended for the stabilization of draw-time concentrations of plasma proteins during changes in temperature storage.
• In February 2024, Bio-Rad Laboratories, Inc., a leading global manufacturer of specialized technological products for the research and clinical diagnostics market, launched the Vericheck ddPCR Replication Competent Lentivirus Kit and the Vericheck ddPCR Replication Competent AAV Kit.

Geographical Insights

North America

North America dominated the sickle cell anemia testing and screening market in 2024. The presence of leading global laboratories and government support with incentives and investment for the healthcare infrastructure boosts the market growth. Furthermore, the government has also introduced newborn screening programs for early detection and treatment of sickle cell disease. Moreover, an increase in awareness campaigns and investments from the private sector contribute to the sickle cell anemia testing and screening market.

Europe

Europe is predicted to be the fastest-growing region for the sickle cell anemia testing and screening market in the forecasted period of 2025-2034. This was due to the increase in awareness and government support in healthcare and advanced diagnostics and research facilities. Many countries in Europe have now introduced and increased newborn screening for sickle cell disease, and a few of them have integrated this into routine neonatal care, ensuring early detection and treatment.

Competitive Landscape

The sickle cell anemia testing and screening market is highly competitive, with leading companies all over the globe. Companies that hold the largest market share are Streck, Inc., Daktari Diagnostics, Biomedomics Inc., Laboratory Corporation of America Holdings, Request A Test, Ltd, Halcyon Biomedical Incorporated, Silver Lake Research Corporation, and Bio-Rad Laboratories, Inc.

The market is dominated by several companies, but the companies that are renowned for their contribution to the market are listed below:

• Company Name: Laboratory Corporation of America Holdings
• Year of Incorporation: 1994
• Headquarters: Burlington, North Carolina, USA.

Labcorp Holding Inc. is a leading global company providing laboratory services for healthcare and diagnosis. It is one of the largest clinical laboratory networks, with operations throughout the world in 100 different countries.

• Company Name: Bio-Rad Laboratories, Inc.
• Year of Incorporation: 1952
• Headquarters: Berkeley, California

Bio-Rad Laboratories, Inc. is a leading global manufacturer of specialized technological products for the research and clinical diagnostics market. The company’s products include content for drug discovery, gene expression, cell biology, protein purification, and many more.

• Company Name: Streck, Inc.
• Year of Incorporation: 1971
• Headquarters: La Vista, Nebraska, USA.

Streck, Inc. is a leading global developer and manufacturer of laboratory products used in research and development for clinical and laboratories. The company has a significant presence in the market for the production of quality control products used in laboratories.